Taurine and Nitrate Supplementation on Thermoregulatory in T2DM
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: taurine, Beetroot and taurine, Placebo.
- Who it may be relevant to
- Registry conditions: Type 2 Diabetes. Basic parameters: from 35 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Taurine and Nitrate Supplementation on Thermoregulatory Responses in People With Type 2 Diabetes Mellitus.
Overview
Anthropogenic warming is increasing the frequency and intensity of extreme heat events. Elevated temperatures raise the risk of mortality and hospital admissions, particularly among people with chronic illnesses such as type 2 diabetes mellitus (T2DM). Globally, around 530 million people live with T2DM , and in the United Kingdom nearly six million are affected, creating a substantial population vulnerable to heat related illness. People with T2DM are at heightened risk of cardiovascular disease, which can impair cardiac output, a key component of thermoregulation, as it supports increased skin blood flow for heat dissipation. T2DM also attenuates eccrine sweat gland function, peripheral vasodilation, reducing evaporative cooling capacity. These physiological constraints highlight the need for effective strategies to improve heat tolerance in this group. Recent evidence shows that exogenous taurine supplementation can enhance sweating in healthy individuals, potentially improving heat loss. This study will examine whether acute taurine supplementation, alone or combined with beetroot, can limit rises in core temperature in people with T2DM during an acute extreme heat exposure.
Detailed description
Anthropogenic warming is increasing the likelihood of extreme heat events. These events, defined as periods of abnormally hot weather lasting several consecutive days, are predicted to rise in both temperature and frequency . Extreme heat increases global mortality with people suffering from chronic conditions being especially vulnerable. A growing body of evidence suggests excess mortality may partly result from increased cardiovascular strain. This is particularly relevant for people with Type 2 Diabetes Mellitus (T2DM) who have both an elevated cardiovascular mortality risk independent of heat stress and a compromised ability to regulate their body temperature during heat stress . This likely explains the increase in hospitalisation and mortality in people with T2DM typically observed during heat waves.
People with T2DM are characterised by progressive insulin resistance over a sustained period, reducing the body's ability to effectively metabolise glucose leading to chronic hyperglycaemia. Consequences of chronic hyperglycaemia are micro and macrovascular dysfunction which lead to an increase in cardiovascular disease (CVD) risk and mortality. Heat stress also produces greater heat strain in people with T2DM compared to the rest of the population . This is potentially derived through an attenuated thermoregulatory response to heat stress in people with T2DM, reducing heat dissipation due to impaired sweating, endothelial and cardiac function , skin blood flow and nitric oxide (NO) bioavailability. These factors increase the risk of heat-related illness. Importantly, advanced heat illness is driven in part by systemic inflammation which highlights the need for targeted interventions that can support endogenous anti inflammatory defences in individual with T2DM during exposure to high heat events.
One such intervention may be supplementation with taurine, an amino acid. Taurine shows promise as a thermoregulatory aid during extreme heat, as it promotes faster onset of sweating, greater sweat loss, reduced heat accumulation and enhanced evaporative cooling in healthy populations. As an antioxidant, taurine may also improve inflammation and redox balance by increasing NO bioavailability via increased stability of tetrahydrobiopterin (BH4) in NO synthase and reduced NO scavenging. Beetroot is another antioxidant rich supplement that also increases the bioavailability of NO via the stepwise reduction of nitrate to nitrite and subsequently to NO. Ultimately, this will improve macro and microvascular function in people with chronic disease and may help with thermoregulation during extreme heat. Taurine and nitrate are well tolerated even at high doses in long term clinical trials, whilst taurine's and nitrates capacity to stabilise mitochondrial function provides a biologically plausible means of reducing heat induced oxidative stress.
Taurine and nitrate may therefore offer safe, low-cost interventions to reduce oxidative stress and inflammation, to enhance blood flow and improve evaporative heat loss during heat stress. We hypothesise that taurine and nitrate supplementation will improve the sweating response and reduce the rate of core temperature rise compared to placebo in people with T2DM after exercise in acute heat event. Secondary hypotheses are that the supplements will improve: (1) macro and micro vascular function (2), skin blood flow and (3) redox balance.
Interventions
- Dietary supplement taurine
The taurine supplement will be administered as a 5g (100% taurine powder, myprotein, UK) dose. To taste match the beetroot arm we will use a nitrate depleted powder. The placebo contained 1.6% nitrate (180 mg nitrate; Bio-gen Extracts Private Limited, Karnataka, India). The servings contained 13.33g of nitrate depleted beetroot powder. The remaining 6.67g comprised a sweetener (stevia), flavour (watermelon) and flavouring agents (malic \& citric acid). The beetroot powders were prepared by manip - Dietary supplement Beetroot and taurine
20g of formulated beetroot power containing \~6% nitrate (800mg NO3-; TruBeet; Bio-gen Extracts Private Limited). The servings contained 13.33g of the formulated beetroot powder. The remaining 6.67g comprised a sweetener (stevia), flavour (watermelon) and flavouring agents (malic \& citric acid) and 5g (100% taurine powder, myprotein, UK) of taurine will also be added to 305mL water prior to ingestion. - Dietary supplement Placebo
Placebo will include the 20g nitrate placebo from above and 5g of maltodextrin (100% Maltodextrin Carbs, myprotein, UK) which will also be added to 305 mL water.
Primary outcome measures
- Whole body sweat rate [Time frame: Baseline and immediately post heating (3 hour post-baseline)]
Secondary outcome measures (12)
- Local sweat rate: [Time frame: through study completion, average 1 week]
- Rectal temperature Trec [Time frame: through study completion, average 1 week]
- Skin temperature: Tsk [Time frame: through study completion, average 1 week]
- Mean Body temperature [Time frame: through study completion, average 1 week]
- Cardiac output [Time frame: through study completion, average 1 week]
- Macrovascular function [Time frame: Baseline and immediately post heating (3 hour post-baseline)]
- Microvascular function [Time frame: Baseline and immediately post heating (3 hour post-baseline)]
- Heart rate [Time frame: through study completion, average 1 week]
- Biomarkers [Time frame: Baseline and immediately post heating (3 hour post-baseline)]
- Muscle peripheral oxygenation [Time frame: through study completion, average 1 week]
- Hydration levels: [Time frame: Baseline and immediately post heating (3 hour post-baseline)]
- Thermal sensation [Time frame: through study completion, average 1 week]
Eligibility criteria
Inclusion criteria
- Male or female (post-menopausal) aged 35 years or above.
- Diagnosed with T2DM as defined by the WHO (HbA1c ≥48 mmol/mol).
- Willing and able to give informed consent for participation in the study.
- Able to understand and fully cooperate with the study protocol.
Exclusion criteria
- Severe peripheral neuropathy (to the point to which they cannot sense temperature)
- Uncontrolled hypertension (≥180 systolic / 100 diastolic)
- Significant renal impairment (eGFR < 30)
- Diagnosed anhidrosis
- Taking any medication which may interfere with data interpretation or safety
- Who have had a myocardial infarction or cerebrovascular event
- Any cardiac abnormalities which restrict hard exercise
- Any allergies to the ingredients used in the supplements
- BMI >40
- Current smokers or who have stopped within 3 months
- Unable to understand and/or fully cooperate with the study protocol
- Any serious medical condition which would interfere with data interpretation or safety will be excluded from participation.
- Open wounds
- Skin ulcerations (that would interfere with data collection and interpretation or safety)
- Eczema (that would interfere with data collection and interpretation or safety)
- Pre-existing postural hypertension
- Existing cardiac diseases (identified during screening)
- Currently heat acclimated (repeated exposure to hot environments ≥3 sessions in the last 14-21 days)
- Prior heat related illness
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07656051 · 370139 · UP/226698